Get started
Author

Ilnaz Rahimmanesh

Observed names: I Rahimmanesh, ILNAZ Rahimmanesh, Ilnaz Rahim-Manesh, Rahimmanesh Ilnaz, Rahimmanesh, Ilnaz
ORCID: 0000-0003-3438-1959
Observed ORCID: 0000-0003-3438-1959
OpenAlex ID: A5060455651
Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery Applications
2022 · Sakineh Hajebi, Satar Yousefiasl, et al. · Advanced Healthcare Materials · 62
PDF
Advances in aptamer-based drug delivery vehicles for cancer therapy
2022 · Kousar Ghasemii, Mahdieh Darroudi, et al. · Biomaterials Advances · 54
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
2016 · Laleh Shariati, Hossein Khanahmad, et al. · The Journal of Gene Medicine · 51
MicroRNAs as the actors in the atherosclerosis scenario
2019 · Fatemeh Hajibabaie, Shirin Kouhpayeh, et al. · Journal of Physiology and Biochemistry · 46
Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering
2023 · Laleh Shariati, Yasaman Esmaeili, et al. · Environmental Research · 41
Nucleic acid-based therapeutics for dermal wound healing
2022 · Preety Sharma, Arun Kumar, et al. · International Journal of Biological Macromolecules · 38
miRNA ‐encapsulated abiotic materials and biovectors for cutaneous and oral wound healing: Biogenesis, mechanisms, and delivery nanocarriers
2022 · Asmita Deka Dey, Satar Yousefiasl, et al. · Bioengineering & Translational Medicine · 37
Disruption of SOX6 gene using CRISPR/Cas9 technology for gamma‐globin reactivation: An approach towards gene therapy of β‐thalassemia
2018 · Laleh Shariati, Fattah Rohani, et al. · Journal of Cellular Biochemistry · 37
A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma
2023 · Azadeh Rahimi, Yasaman Esmaeili, et al. · European Journal of Pharmaceutical Sciences · 36
The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
2021 · Shirin Kouhpayeh, Laleh Shariati, et al. · International Journal of Molecular Sciences · 35
Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis
2017 · Fereshteh Alsahebfosoul, Ilnaz Rahimmanesh, et al. · BioMolecular Concepts · 32
The Molecular Story of COVID-19; NAD+ Depletion Addresses All Questions in this Infection
2020 · Shirin Kouhpayeh, Laleh Shariati, et al. · Preprints.org · 31
Cancer Occurrence as the Upcoming Complications of COVID-19
2022 · Ilnaz Rahimmanesh, Laleh Shariati, et al. · Frontiers in Molecular Biosciences · 28
PDF
Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer
2024 · Yasaman Esmaeili, Arezou Dabiri, et al. · Biomedicine & Pharmacotherapy · 27
The challenging nature of primary T lymphocytes for transfection: Effect of protamine sulfate on the transfection efficiency of chemical transfection reagents
2020 · Hossein Khanahmad, Ilnaz Rahimmanesh, et al. · Research in Pharmaceutical Sciences · 22
The silencing effect of miR-30a on ITGA4 gene expression in vitro: an approach for gene therapy
2017 · Hossein Khanahmad, MohammadAmin Tabatabaiefar, et al. · Research in Pharmaceutical Sciences · 22
Phage based vaccine: A novel strategy in prevention and treatment
2023 · Sharareh Mohammad Hasani, Elham Ghafouri, et al. · Heliyon · 20
The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies
2023 · Azadeh Rahimi, Zahra Malakoutikhah, et al. · Cancer Cell International · 19
PDF
Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)
2020 · Ilnaz Rahimmanesh, Razieh Fatehi · Clinical and Translational Medicine · 18
PDF
Conceptual Framework for SARS-CoV-2–Related Lymphopenia
2022 · Ilnaz Rahimmanesh, Shirin Kouhpayeh, et al. · Advanced Biomedical Research · 16
Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells
2017 · Farzaneh Rami, Shamsi Naderi Beni, et al. · Cellular Reprogramming · 15
Targeting the CCL2/CCR2 axis in colorectal cancer: Immunopharmacological perspectives and therapeutic strategies
2025 · Fatemeh Hajibabaie, Navid Abedpoor, et al. · Critical Reviews in Oncology/Hematology · 14
Exploring metal-organic frameworks in gene delivery: From prostate to lung therapeutics
2024 · Moein Safarkhani, Nasim Dana, et al. · Applied Materials Today · 13
Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy
2021 · Mina Mirian, Shirin Kouhpayeh, et al. · Molecular Biology Reports · 13
The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy
2023 · Fatemeh Hajibabaie, Navid Abedpoor, et al. · Environmental Research · 12
Works count: 70
Citation count: 892
H-index: 18
I10-index: 29
Year
Topic
Type